COMMUNIQUÉS West-GlobeNewswire

Histogenics Corporation to Present at Upcoming Investor Conferences

28/03/2018 - 14:30

WALTHAM, Mass., March 28, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX ), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored [...]

Multiple New Studies Demonstrate T2 Biosystems’ Diagnostics Improve Detection of Sepsis Causing Pathogens Over Blood Culture-based Diagnostics

28/03/2018 - 14:30

LEXINGTON, Mass., March 28, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO ), an emerging leader in the development and commercialization of innovative medical diagnostic products, announces the publication [...]

Paratek Pharmaceuticals to Present at the H.C. Wainwright Annual Global Life Sciences Conference

28/03/2018 - 14:00

BOSTON, March 28, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK ) today announced that President, Chief Operating Officer and Chief Medical Officer, Evan Loh, MD will present at the upcoming H.C. [...]

Apricus Biosciences Announces Pricing of $3.55 Million Public Offering

28/03/2018 - 14:00

SAN DIEGO, March 28, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI ), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it has priced a [...]

BioSig Announces Submission of FDA 510(k) Application for PURE EP System

28/03/2018 - 14:00

Santa Monica, CA, March 28, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM) announced that the Company has filed 510(k) application to the U.S. Food and Drug Administration (FDA) for its first [...]

Aptose Biosciences Establishes New At-the-Market Facility

28/03/2018 - 14:00

SAN DIEGO and TORONTO, March 28, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO ) (TSX: APS ), a clinical-stage company developing highly differentiated therapeutics that [...]

Albireo to Present Clinical Data on A4250 at The International Liver Congress™ 2018

28/03/2018 - 14:00

BOSTON, March 28, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO ), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that new data from its [...]

Actinium Pharmaceuticals Announces Collaborative Research Partnership with Astellas Leveraging Actinium’s AWE Platform Technology

28/03/2018 - 14:00

- Collaborative research agreement will utilize Actinium’s AWE Technology Platform to generate Actinium Radio-Conjugates on selected Astellas targeting agents - Actinium to perform preclinical validation studies on [...]

FDA Grants Orphan Drug Designation to Cynata’s Lead Cymerus™ MSC Product, CYP-001

28/03/2018 - 14:00

MELBOURNE, Australia, March 28, 2018 (GLOBE NEWSWIRE) -- Australian stem cell and regenerative medicine company Cynata Therapeutics Limited (ASX:CYP) is pleased to announce that the United States Food and Drug [...]

BIOPHYTIS: 2017 Full Year Results

28/03/2018 - 14:00

Launch and progress in the SARA-OBS observational clinical study in the United States, Belgium, France, and Italy; Agencies’ authorizations of SARA-INT phase 2b interventional clinical study in the United States and [...]

3D Signatures Collaborates with MDxHealth to Evaluate Telo-PC™ Test in Prostate Cancer

28/03/2018 - 14:00

TORONTO, March 28, 2018 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V: DXD ) (OTCQB:TDSGF) (FSE:3D0) (the “Company” or " 3DS "), a personalized medicine company with a proprietary software platform (TeloView TM ) based [...]

Glycotope Selects CrownBio as a Preclinical Development Partner to Advance Their Immunotherapeutic Pipeline

28/03/2018 - 14:00

SAN DIEGO, March 28, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing [...]

Avenue Therapeutics Receives Notices of Allowance for Patent Applications Covering Methods of Administration for Intravenous Tramadol

28/03/2018 - 14:00

NEW YORK, March 28, 2018 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI ) (“Avenue”), a company focused on the development and commercialization of intravenous (IV) tramadol, today announced receipt of [...]

Inovalon Announces New Post Acute Care Services Agreement with Tenet Healthcare

28/03/2018 - 13:55

BOWIE, Md., March 28, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV ), a leading technology company providing advanced, cloud-based platforms empowering a data-driven transformation from volume-based to value-based [...]

Precipio Files Patent for Non-Invasive Cell Capture Device For Gynecological Cancer Detection

28/03/2018 - 13:37

In collaboration with Yale, feminine panty liner designed to remove obstacles to early detection NEW HAVEN, Conn., March 28, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO ), [...]

MacroGenics Announces Pricing of Public Offering of Common Stock

28/03/2018 - 13:30

ROCKVILLE, MD, March 28, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]

Mersana Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Provides Business Updates

28/03/2018 - 13:30

Enrollment on Track for Phase 1 Trial of XMT-1522 Patients with Advanced Tumors Expressing HER2 Progressing Phase 1 Trial of XMT-1536, First-in-Class Dolaflexin ® Antibody Drug Conjugate Targeting NaPi2b Appointed David [...]

ICC Labs Signs Term Sheet to Acquire Equity Stake in Strategic Partner and Enter the European Market

28/03/2018 - 13:30

Highlights of proposed transaction, include ICC gaining: Access to five important European markets: Germany, United Kingdom, Spain, Italy and France. Use of an established multi-channel distribution network for CBD [...]

Immunovaccine Announces Initiation of Patient Dosing in Investigator-Sponsored Phase 2 Clinical Trial of Its Lead Candidate DPX-Survivac Used in Combination with Pembrolizumab in Patients with DLBCL

28/03/2018 - 13:05

HALIFAX, Nova Scotia, March 28, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced that the first patient has been treated in a Phase 2 Study [...]